Cases & Deals

Baxter Ventures invests in TVA Medical

Client(s) Baxter International Inc.

Jones Day represented Baxter Ventures in connection with its purchase of Series C Preferred Stock in a private placement by TVA Medical, Inc., a developer of minimally invasive therapies for end-stage renal disease. The round was led by newly vested Baxter Ventures and joined by new investor Boston Scientific and returning investors Sante Ventures, S3 Ventures, and TriStar Technology Ventures.